|
Quotes & Info
|
| DVAX > SEC Filings for DVAX > Form 8-K on 28-Aug-2012 | All Recent SEC Filings |
28-Aug-2012
Other Events, Financial Statements and Exhibits
On August 28, 2012, we issued a press release titled "Dynavax Announces FDA Advisory Committee to Review HEPLISAV(TM)." A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.
(d) Exhibits. The following exhibit is furnished herewith:
99.1 Press Release, dated August 28, 2012, titled "Dynavax Announces FDA Advisory Committee to Review HEPLISAV(TM)."
|
|